Bibliography
- Robert G et al. “Meta-analysis: Antithrombotic therapy to prevent
stroke in patients who have. Nonvalvular Atrial Fibrillation” J Am
Coll Cardiol 2017;70,2964-75
- Ruff CT et al. “Comparison of the efficacy and safety of new oral
anticoagulants with warfarin in patients with atrial fibrillation: a
meta-analysis of randomized trials” Lancet 2014;338:955-62
- Bungard TJ et al. “Why do patients with atrial fibrillation not
receive warfarin?” Arch intern Med 2000;160:41-6
- Marcus F et al. “Left atrial appendage thrombus is not uncommon in
patients with acute atrial fibrillation and a recent embolic event: A
transesophageal echocardiographic study” JACC 1995:452-9
- Reddy VY et al. “5-Years outcomes after left atrial appendage closure
forme the PREVAIL and PROTECT AF trials” JACC 2017;70(24):2964-2975
- Saw J et al. “Early Canadian Multicenter Experience With Watchamn for
Percutaneous Left Atrial Appendage Closure” J Cardiovasc
Electrophysiol 2017 Apr;28(4):396-401
- Gianni C et al. “Closure of the left atrial appendage using
percutaneous transcatheter occlusion devices” J Cardiovasc
Electrophysiol 2020 Aug;31(8):2179-2186
- Gasperetti A et al. “A left atrial appendage closure combined
procedure review: Past, present and future perspectives” J Cardiovasc
Electrophysiol 2019;30(8):1345-1351
- Phillips KP et al. “Combining Watchman left atrial appendage closure
and catheter ablation for atrial fibrillation: multicentre registry
results of feasibility and safety during implant and 30 days
follow-up” Europace 2018;20(6):949-955
- Kawakami H et al. “Cost-effectiveness of combined catheter ablation
and left atrial appendage closure for symptomatic atrial fibrillation
in patients with high stroke and bleeding risk” Am Heart J
2021;231:110-120
- Jiantao Y et al. “Long-term safety and efficacy of combined
percutaneous LAA and PFO/ASD closure: a single-center experience”
Expert Rev Devices 2019;16(5):429-435
- Zhang ZH et al. “One-stop shop: Safety and efficacy of combining
atrial septal defect occlusion and left atrial appendage closure for
patients with atrial septal defect and atrial fibrillation” BMC
Cardiovasc Disord. 2020;20(1):444
- Reynolds D et al. “Micra Transcatheter Pacing Study Group. A leadless
intra- cardiac transcatheter pacing system” N Engl J Med
2016;374:533-541.
- Regoli F. et al. “Combined left atrial appendage closure and
pacemaker implant through a single right femoral vein access” Pacing
Clin Electrophysiol 2016;39:900-902.
- Regoli F et al. “Potential Clinical Utility and Feasibility of
Combined Left Atrial Appendage Closure and Positioning of Miniaturized
Pacemaker Through a Single Right Femoral Vein Access” Am J Cardiol
2017;120:236-242
- Kleinecke C et al. “Amplatzer left atrial appendage closure: Single
versus combined procedures” Catheter cardiovasc interv. 2020
10.1002/ccd.29271
- Tzikas A et al. “Percutaneous left atrial appendage occlusion: the
Munich consensus document on definitions, endpoints, and collection
requirements for clinical studies” Europace 2017;(19)4-15:10.1093
- Holmes DR et al., for the PROTECT AF Investigators. “Percutaneous
closure of the left atrial appendage versus warfarin therapy for
prevention of stroke in patients with atrial fibrillation: a
randomised non-inferiority trial” Lancet 2009;374: 534–4
- Schulman, S. et al. “Definition of major bleeding in clinical
investigations of antihemostatic medicinal products in non-surgical
patients” Journal of Thrombosis and Haemostasis 3(4), 692–694.
- Mehran, R. et al. “Standardized bleeding definitions for
cardiovascular clinical trials: a consensus report from the Bleeding
Academic Research Consortium” Circulation, 123(23), 2736–2747.
- Sacco, R. L. et al. “Council on Nutrition, Physical Activity and
Metabolism. (2013). An updated definition of stroke for the 21st
century: a statement for healthcare professionals from the American
Heart Association/American Stroke Association” Stroke, 44(7),
2064–2089.
- Michael Glikson et al. ”EHRA/EAPCI expert consensus statement on
catheter-based left atrial appendage occlusion – an update”
EuroIntervention. 2020 Jan 17;15(13):1133-1180
- Holmes Jr DR et al. ”Prospective randomized evaluation of the
Watchman Left Atrial Appendage Closure device in patients with atrial
fibrillation versus long-term warfarin therapy: the PREVAIL trial” J
Am Coll Cardiol 2014 16;64(11):1186
- Alison Cooper et al. ”Sources of unsafe primary care for older adults:
a mixed-methods analysis of patient safety incident reports” Age
Ageing. 2017 Sep 1;46(5):833-839.
- John E. Morley, MB et al. “Frailty Consensus: A Call to Action” J Am
Med Dir Assoc. 2013 Jun; 14(6): 392–397.
- Jeremy Walston et al. ”Frailty Screening and Interventions:
Considerations for Clinical Practice” Clin Geriatr Med. 2018
Feb;34(1):25-38
- Louis Labrousse et al. ”Guidance of the MitraClip ® procedure by 2D
and 3D imaging” Arch Cardiovasc Dis. Jun-Jul 2018;111(6-7):432-440.
- Turagam MK et al. ”Intracardiac echocardiography-guided implantation
of the Watchman FLX left atrial appendage closure device” J
Cardiovasc Electrophysiol. 2021 Mar;32(3):717-725.
- Gianni C at al. ”Intracardiac echocardiography- versus transesophageal
echocardiography-guided left atrial appendage occlusion with Watchman
FLX” J Cardiovasc Electrophysiol. 2021 Oct;32(10):2781-2784.
- John Fanourgiakis et al. ”Cost-of-illness study of patients subjected
to cardiac rhythm management devices implantation: results from a
single tertiary centre” Europace. 2013 Mar;15(3):366-75.
- Clifford J. Kavinsky et al. ”SCAI/ACC/HRS Institutional and Operator
Requirements for Left Atrial Appendage Occlusion” J Am Coll Cardiol.
2016 May 17;67(19):2295-2305.